Soluble adenylyl cyclase inhibition prevents human sperm functions essential for fertilization.


Journal

Molecular human reproduction
ISSN: 1460-2407
Titre abrégé: Mol Hum Reprod
Pays: England
ID NLM: 9513710

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 28 04 2021
revised: 16 08 2021
pubmed: 1 9 2021
medline: 27 1 2022
entrez: 31 8 2021
Statut: ppublish

Résumé

Soluble adenylyl cyclase (sAC: ADCY10) has been genetically confirmed to be essential for male fertility in mice and humans. In mice, ex vivo studies of dormant, caudal epididymal sperm demonstrated that sAC is required for initiating capacitation and activating motility. We now use an improved sAC inhibitor, TDI-10229, for a comprehensive analysis of sAC function in mouse and human sperm. In contrast to caudal epididymal mouse sperm, human sperm are collected post-ejaculation, after sAC activity has already been stimulated. In addition to preventing the capacitation-induced stimulation of sAC and protein kinase A activities, tyrosine phosphorylation, alkalinization, beat frequency and acrosome reaction in dormant mouse sperm, sAC inhibitors interrupt each of these capacitation-induced changes in ejaculated human sperm. Furthermore, we show for the first time that sAC is required during acrosomal exocytosis in mouse and human sperm. These data define sAC inhibitors as candidates for non-hormonal, on-demand contraceptives suitable for delivery via intravaginal devices in women.

Identifiants

pubmed: 34463764
pii: 6360468
doi: 10.1093/molehr/gaab054
pmc: PMC8473925
pii:
doi:

Substances chimiques

Adenylyl Cyclase Inhibitors 0
ADCY10 protein, human EC 4.6.1.1
Adenylyl Cyclases EC 4.6.1.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM073546
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG069501
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD088571
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD069631
Pays : United States
Organisme : NICHD NIH HHS
ID : F31 HD105363
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD100549
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Development. 2003 Apr;130(7):1317-26
pubmed: 12588848
Biol Reprod. 2005 Jan;72(1):22-32
pubmed: 15342355
J Cell Physiol. 2017 Jun;232(6):1404-1414
pubmed: 27714810
Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):79-84
pubmed: 9874775
Nature. 2006 Feb 9;439(7077):737-40
pubmed: 16467839
Dev Biol. 1996 Feb 1;173(2):510-20
pubmed: 8606009
Dev Biol. 2006 Aug 15;296(2):353-62
pubmed: 16842770
PLoS Med. 2018 Sep 28;15(9):e1002655
pubmed: 30265679
J Biol Chem. 2003 May 2;278(18):15922-6
pubmed: 12609998
ACS Med Chem Lett. 2021 Jul 14;12(8):1283-1287
pubmed: 34413957
Biochim Biophys Acta. 2016 Apr;1863(4):544-61
pubmed: 26704387
J Pharm Sci. 2012 Aug;101(8):2833-43
pubmed: 22619076
J Biol Chem. 1995 Mar 31;270(13):7573-9
pubmed: 7706305
Nat Chem Biol. 2016 Oct;12(10):838-44
pubmed: 27547922
Cell. 1992 Feb 7;68(3):479-89
pubmed: 1739965
Dev Cell. 2005 Aug;9(2):249-59
pubmed: 16054031
Development. 1995 Apr;121(4):1129-37
pubmed: 7743926
PLoS One. 2014 Mar 05;9(3):e88509
pubmed: 24599325
Pharmacol Ther. 2018 Oct;190:173-186
pubmed: 29807057
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2610-20
pubmed: 25066614
J Pharmacol Exp Ther. 2013 Dec;347(3):589-98
pubmed: 24091307
PLoS Med. 2021 Feb 3;18(2):e1003495
pubmed: 33534791
Fertil Steril. 2021 Apr;115(4):930-939
pubmed: 33461755
J Biol Chem. 2013 Nov 15;288(46):33283-91
pubmed: 24100033
Front Cell Dev Biol. 2018 Jul 27;6:72
pubmed: 30105226
PLoS One. 2018 Jun 28;13(6):e0199778
pubmed: 29953547
Cells. 2018 Dec 26;8(1):
pubmed: 30587820
Hum Reprod. 2019 Jun 4;34(6):1155-1164
pubmed: 31119281
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7688-92
pubmed: 17460039
Mol Cell Endocrinol. 2018 Jun 15;468:111-120
pubmed: 29146556
J Physiol. 1971 Mar;213(3):557-70
pubmed: 5551402
Mol Hum Reprod. 2013 Sep;19(9):570-80
pubmed: 23630234
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2993-8
pubmed: 14976244
Biochem Biophys Res Commun. 2014 Aug 1;450(3):1149-58
pubmed: 24887564
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):175-182
pubmed: 29135651
Elife. 2016 Mar 22;5:
pubmed: 27003291
Front Cell Dev Biol. 2020 Jan 17;7:366
pubmed: 32010689
Cells. 2019 Jun 27;8(7):
pubmed: 31252584

Auteurs

Melanie Balbach (M)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Lubna Ghanem (L)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Thomas Rossetti (T)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Navpreet Kaur (N)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Carla Ritagliati (C)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.
Laboratory of Cell Signal Transduction Networks, Instituto de Biología Molecular y Celular de Rosario, Rosario, Argentina.

Jacob Ferreira (J)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Dario Krapf (D)

Laboratory of Cell Signal Transduction Networks, Instituto de Biología Molecular y Celular de Rosario, Rosario, Argentina.

Lis C Puga Molina (LC)

Department of OB/GYN, Washington University School of Medicine, Saint Louis, MO, USA.

Celia Maria Santi (CM)

Department of OB/GYN, Washington University School of Medicine, Saint Louis, MO, USA.

Jan Niklas Hansen (JN)

Biophysical Imaging, Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.

Dagmar Wachten (D)

Biophysical Imaging, Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.

Makoto Fushimi (M)

Tri-Institutional Therapeutics Discovery Institute, New York City, NY, USA.

Peter T Meinke (PT)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.
Tri-Institutional Therapeutics Discovery Institute, New York City, NY, USA.

Jochen Buck (J)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Lonny R Levin (LR)

Department of Pharmacology, Weill Cornell Medicine, New York City, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH